Cited by 224Hepatitis Viruses Studies and EpidemiologyHepatitis B Virus StudiesTravel-related health issues

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Clinical experience with an inactivated hepatitis A vaccine.

Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., Andre, F. E.·1995·Journal of Infectious Diseases

Open this paper in CoChat — free account

Abstract

Clinical trials of an inactivated hepatitis A vaccine have encompassed 104 studies completed by December 1993 in 27 countries. Studies involved 50,677 subjects and administration of > 120,000 vaccine doses. Results show that the vaccine is safe, clinically well-tolerated, and highly immunogenic in all age groups. A seroconversion rate of 100% is achieved 1 month after primary vaccination. Vaccine-induced antibody titers persist after a primary vaccination course for > or = 1 year with a single dose of 1440 ELISA units (EL.U.) in adults and after two doses of 360 EL.U. in children. A booster dose 6-12 months after the first vaccine dose induces very high antibody titers, which according to a mathematical model, are expected to protect against hepatitis A for > 20 years. The vaccine is equally immunogenic when administered simultaneously with other traveler vaccines, therefore enabling flexible and convenient vaccination against hepatitis A.

Integrity signals

Registry

Crossref · 10.1093/infdis/171.supplement_1.s44

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Protection Against Hepatitis A by an Inactivated Vaccine
Innis, B. L. (1994) · JAMA · doi:10.1001/jama.1994.03510410040030 · Cited by 459
Epidemiological patterns of hepatitis A in different parts of the world
Gust, I. D. (1992) · Vaccine · doi:10.1016/0264-410x(92)90544-t · Cited by 172
Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistence
Damme, P. V., Thoelen, S., Cramm, M., Groote, K. D., Safary, A., & Meheus, A. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440425 · Cited by 158
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings
André, F. E., d'Hondt, E., Delem, A., & Safary, A. (1992) · Vaccine · doi:10.1016/0264-410x(92)90576-6 · Cited by 150
Serum Neutralizing Antibody Response to Hepatitis A Virus
Lemon, S. M., & Binn, L. N. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1033 · Cited by 140
Immunoglobulin prophylaxis for hepatitis A.
Winokur, P. L., & Stapleton, J. T. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.580 · Cited by 136 · cited 1×
“Although immune serum globulin (ISG) offers effective passive protection (~-85%) against hepatitis A for travelers [9], patient compliance is low because of a number of factors including lack of information on availability, its cost, injection site pain, and the fact that immunoglobulins are bloodderived products.”
Background
Inactivated candidate vaccines for hepatitis A.
André, F. E., Hepburn, A., & d'Hondt, E. (1990) · PubMed · Cited by 106
Immunogenicity and safety of an inactivated hepatitis a vaccine in anti‐HIV positive and negative homosexual men
Heß, G., Clemens, R. L., Bienzle, U., Schönfeld, C., Schunck, B., & Bock, H. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890460109 · Cited by 94
Interruption of an outbreak of hepatitis A in two villages by vaccination
Prikazský, V., Oleár, V., Cernoch, A., Safary, A., & André, F. E. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440427 · Cited by 93
Production, quality control and characterization of an inactivated hepatitis A vaccine
Peetermans, J. (1992) · Vaccine · doi:10.1016/0264-410x(92)90557-z · Cited by 83

Show all 23 references

Sorted by citations

Items 101–200 of 224

Initial evaluation of universal immunization with a single dose against hepatitis A virus in Central Brazil
de Brito, W. I., Alves, E. R., de Oliveira, R. M., & Souto, F. J. D. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.04.001 · Cited by 17
Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
Liu, J., Mao, Q., Wu, X., He, Q., Bian, L., Bai, Y., Wang, Z., Wang, Q., Zhang, J., Liang, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814365 · Cited by 15
HEPATITIS A VACCINE
Bell, B. P. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200012000-00015 · Cited by 15
Hepatitis A Virus
Robertson, B. H., & Bell, B. P. (2003) · Wiley eBooks · doi:10.1038/npg.els.0001026 · Cited by 14
Vaccination for the expatriate and long-term traveler
Shepherd, S. M., & Shoff, W. H. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.913485 · Cited by 13
“These vaccines, which demonstrate high immunogenicity and safety, are appropriate for all longterm and expatriate travelers to low- and moderate-income countries due to cumulative risk of exposure [73].”
Background
Hepatitis A: A preventable threat
Leung, A. K. C., Kellner, J. D., & Davies, H. D. (2005) · Advances in Therapy · doi:10.1007/bf02849951 · Cited by 13
Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease.
El-Karaksy, H. M., El-Sayed, R., El‐Raziky, M. S., El-Koofy, N., & Mansour, S. (2008) · PubMed · Cited by 13
History of U.S. Military Contributions to the Study of Viral Hepatitis
Dooley, D. P. (2005) · Military Medicine · doi:10.7205/milmed.170.4s.71 · Cited by 13
Hepatitis A and B Infections Among Expatriates in Papua New Guinea: A Missed Opportunity for Immunization
Poland, G. A., Axelsen, P. H., & Felz, M. W. (1996) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1996.tb00748.x · Cited by 13
IMMUNIZATIONS FOR INTERNATIONAL TRAVEL
Jong, E. C. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70004-0 · Cited by 13
Adult Travelers with HIV Infection
Gompel, A. V., Kozarsky, P. E., & Colebunders, R. (1997) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1997.tb00801.x · Cited by 13
Hepatitis A Vaccines
Averhoff, F. M., Khudyakov, Y. E., & Nelson, N. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00024-9 · Cited by 12
Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis.
Beran, J., Dědek, P., Štěpánová, V., Spliio, M., & Pozler, O. (2005) · PubMed · Cited by 12
VIRAL HEPATITIS
Jonas, M. M. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70145-8 · Cited by 12
Hepatitis A and E Infection in International Travellers
Torresi, J., & Johnson, D. F. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0179-7 · Cited by 11
“Vaccination induces neutralizing antibody in 54% to 88% of recipients by day 14 after the first dose, 90% after 24 days, and in 100% by 1 month [11, 12].”
Background
Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens
Lu, M., Chang, M., Tsai, K., & Chen, D. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00149-2 · Cited by 11
An epidemiologic study on the seropositive rate of hepatitis A virus among a selected group of children and adults in Busan
Kwon, Y. O., Choi, I. J., Jung, J. W., & Park, J. H. (2007) · Korean Journal of Pediatrics · doi:10.3345/kjp.2007.50.3.262 · Cited by 11
REVIEW: Hepatitis A, Hepatitis B, and Combination Hepatitis Vaccines for Immunoprophylaxis: An Update
Koff, R. S. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015397807278 · Cited by 11
Adult Immunizations: Recommendations for Practice
Reid, K. C., Grizzard, T. A., & Poland, G. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.4.377 · Cited by 11
Licensure of Inactivated Hepatitis A Vaccine and Recommendations for Use Among International Travelers
(1996) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1996.tb00703.x · Cited by 11
Vaccination of travelers: how far have we come and where are we going?
Chen, L. H., Hill, D. R., & Wilder‐Smith, A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.138 · Cited by 10
Predictors of humoral response to recommended vaccines in HIV-infected adults
Tsachouridou, Ο., Christaki, E., Skoura, L., Georgiou, A., Nanoudis, S., Vasdeki, D., Ntziovara, M.-A., Kotoreni, G., Forozidou, E., Tsoukra, P., et al. (2017) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2017.07.006 · Cited by 10
Hepatitis A vaccines
Murphy, T. V., Feinstone, S. M., & Bell, B. P. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00008-2 · Cited by 10
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines
Andre, F. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00369-3 · Cited by 10
Epidemiological Investigation of an Outbreak of Hepatitis A at a Residential Facility for the Disabled, 2011
Lim, H., Choi, K., & Lee, S. (2013) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2013.46.2.62 · Cited by 10
“Considering the period needed for antibody production [6], they were isolated until September 3, which was 4 weeks after August 3, which, in turn, was the last vaccination date in the facility.”
Background
Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland
Crisinel, P. A., Posfay-Barbe, K. M., Aebi, C., Cheseaux, J., Kahlert, C. R., Rudin, C., Nadal, D., & Siegrist, C. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00264-12 · Cited by 10
“Immunocompetent children and adults reach nearly 100% seroconversion rates and high GMCs after HAV immunization (6).”
Background
Viral hepatitis and the surgeon
Minuk, G. Y., Cohen, A. J., Assy, N., & Moser, M. (2005) · HPB · doi:10.1080/13651820410016633 · Cited by 10
“Most vaccinated individuals develop protective antibody levels after a single administration of a potent formulation [19].”
Background
Hepatitis A
Previsani, N., Lavanchy, D., & Siegl, G. (2003) · Perspectives in medical virology · doi:10.1016/s0168-7069(03)10001-8 · Cited by 10
Hepatitis A Virus
Wasley, A., Feinstone, S. M., & Bell, B. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00173-9 · Cited by 10
Comparison of Two Immunization Schedules with an Inactivated Hepatitis A Vaccine (AvaximTM)
Vidor, E. J., Ratheau, C., Briantais, P., & Vuillier, D. (1998) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.1998.tb00501.x · Cited by 10
Immunization against Hepatitis A and Hepatitis B Infections
Steffen, R. P. (2001) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2001.tb00541.x · Cited by 10
Hepatitis Vaccines
Koff, R. S. (2001) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70269-5 · Cited by 10
Hepatitis A vaccination policy in Catalonia (Spain)
Sanmartí, L. S., Ferret, M. B., García, A. D., Alcalá, E. N., Clavell, J. B., Rubió, P. P., Morales, P. G., Zaragoza, J. L. T., Cortada, M. B., Tort, J. V., et al. (2000) · Vacunas · doi:10.1016/s1576-9887(00)70186-5 · Cited by 10
Safety and efficacy of hepatitis A vaccine in children with chronic liver disease
El‐Karaksy, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i45.7337 · Cited by 9
Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee, C., Huang, L., Lee, P., Chiu, H. H., Dumas, R., Milcamps, B., & Lin, W. (2000) · PubMed · Cited by 9
Hepatitis A Vaccine: Current Indications
Rosenthal, P. J. (1998) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1998.tb01110.x · Cited by 9
Considerations for HAV vaccine in India
Mathur, P., & Arora, N. K. (1999) · The Indian Journal of Pediatrics · doi:10.1007/bf02752368 · Cited by 8
HEPATITIS VACCINES
Katkov, W. N. (1996) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70485-5 · Cited by 8
Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent Outbreaks.
Moon, A. M., Lowy, E., Maier, M. M., Chartier, M., Morgan, T. R. M., Hoffman-Hōgg, L., & Beste, L. A. (2018) · Europe PMC (PubMed Central) · Cited by 7
Hepatitis A
Arguedas, M. R., & Fallon, M. B. (2004) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-004-0003-7 · Cited by 7
New chemical method of viral inactivation for vaccine development based on membrane fusion inhibition
Stauffer, F., Miranda, J. D., Schechter, M. C., QUEIROZ, F. Á., Santos, N. O., Alves, A. M. B., & Poian, A. T. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.025 · Cited by 7
Ocorrência de um surto de hepatite A em três bairros do município de Vitória (ES) e sua relação com a qualidade da água de consumo humano
da Silva, L. M., de Souza, E. H., Arrebola, T. M., & de Jesus, G. D. A. (2009) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232009000600023 · Cited by 7
PREPARING THE INTERNATIONAL TRAVELER
Nettleman, M. D. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70258-2 · Cited by 7
Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops
Buma, A. P. C. C. H., van Doornum, G. J. J., Veltink, R. L., van Ameijden, E. J. C., Leentvaar-Kuijpers, A., & Coutinho, R. A. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00048-0 · Cited by 7
Changing Epidemiology of Hepatitis A: Time for Vaccination in Childhood
Jelı́nek, T., & Nothdurft, H. D. (2006) · Journal of Travel Medicine · doi:10.2310/7060.2000.00046 · Cited by 6
Hepatitis A: Past and Present
Park, S. H. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.10.996 · Cited by 6
Hepatitis A Virus
Feng, Z., & Lemon, S. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch24 · Cited by 6
Changes in Hepatitis a Virus Seroepidemiology in Hiv-Infected Brazilian Patients
Aloise, R., de Almeida, A. J., Sion, F. S., Morais-de-Sá, C. A., Gaspar, A. M. C., & de Paula, V. S. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2007.007100 · Cited by 6
HEPATITIS
Bondesson, J. D., & Saperston, A. R. (1996) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70275-3 · Cited by 6
Vaccines for international travel
Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00065-3 · Cited by 5
Vacina inativada contra a hepatite A: revisão da literatura e considerações sobre seu uso
Santos, M. V., & Lopes, M. H. (1997) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86821997000200010 · Cited by 5
Routine vaccines across the life span, 2005.
Zimmerman, R. K., Middleton, D. B., Burns, I. T., Clover, R. D., & Kimmel, S. R. (2005) · PubMed · Cited by 5
High immunogenicity and good tolerability of a new hepatitis A vaccine candidate
Langer, B. (1996) · Vaccine · doi:10.1016/0264-410x(96)00080-1 · Cited by 5
New and improved vaccines
Conrad, D. A., & Jenson, H. B. (1996) · Postgraduate Medicine · doi:10.3810/pgm.1996.10.95 · Cited by 5
Hepatitis a vaccination
Orli, T., & Arguedas, M. R. (2006) · Current Hepatology Reports · doi:10.1007/s11901-006-0002-3 · Cited by 4
Hepatitis A
Foster, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819519-2.00023-2 · Cited by 4
Viral Hepatitis: Expanding the Alphabet
Hochman, J. A., & Balistreri, W. F. (1999) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00032-x · Cited by 4
Routine childhood immunizations
Campbell, A. L., & Bryant, K. A. (2001) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70038-5 · Cited by 4
Treatment of hypertensive patients according to the conventional or ambulatory pressure: a progress report on the APTH trial. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension.
Bieniaszewski, L., Staessen, J. A., Polfliet, J., Thijs, L., & Fagard, R. H. (1996) · PubMed · Cited by 4
Hepatitis aguda A en paciente previamente vacunada
Pérez, L. M., & Garcı́a-Retortillo, M. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.05.003 · Cited by 3
Seroepidemiology of Hepatitis A among Healthcare Workers and Their Response to Vaccination Recommendation at a Korean Hospital
Kim, M. S., Kim, E. S., Chang, Y. J., Huh, H. J., Chae, S. L., & Lee, J. H. (2009) · Infection and Chemotherapy · doi:10.3947/ic.2009.41.5.272 · Cited by 3
Characterization of Acute Hepatitis Virus A Genotype in Korea
Kim, M. H., Choi, H., Pak, K. S., Seong, C. N., & Cho, H. W. (2013) · Journal of Life Science · doi:10.5352/jls.2013.23.2.175 · Cited by 3
“백신 안전 성의 경우에 이미 27개국에서 수행된 조사에 따르면 A형 간염 백신은 안전하며, 모든 연령세대에 걸쳐 높은 면역력을 보인 다고 하였다[3].”
Hepatites virais e gestação
Piazza, M. J., & Urbanetz, A. A. (2010) · Cited by 3
Hepatitis A
Sharapov, U. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416041-5.00018-4 · Cited by 3
Interaction with Phospholipid Mono- and Bi-layers of HAV-VP3 (102-121) Sequence by Using Spectroscopic Techniques
Garcı́a, M., Pujol, M., Reig, F., Alsina, M. A., & Haro, I. (1997) · Biomedical Chromatography · doi:10.1002/(sici)1099-0801(199703)11:2 · Cited by 3
Hepatitis A Vaccines
Lewis, J. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-702-4_10 · Cited by 3
Prevention
Bell, B. P. (2005) · doi:10.1002/9780470987131.ch9 · Cited by 3
Comparison of safety and immunogenicity between Healive®, Havrix® and live attenuated Hepatitis A vaccines in pediatric population: a systematic review with meta-analysis
Zeid, M. A., Elrosasy, A., Farho, M. A., Rifai, M. K., Aboelkhier, M. M., Elkhrashy, M. N., Zabady, A. H., Zaki, M. S. A., Hamed, E. M., Dawood, S. A., et al. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01996-8 · Cited by 2
Vaccines for International Travel
Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00071-7 · Cited by 2
Hepatitis A Vaccines
Walsh, N. M., Soeters, H. M., Nelson, N. P., Khudyakov, Y. E., & Weng, M. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00026-8 · Cited by 3
The Current Status in Terms of Vaccination for Individuals Infected with Human Immunodeficiency Virus
Xu, N., Shen, Y., Huang, W., & Nie, J. (2025) · Viruses · doi:10.3390/v17020171 · Cited by 2
“Furthermore, NIH advises that previously VZV-vaccinated HIV-infected adults who are over 19 years old should receive two doses of the recombinant herpes zoster vaccine [22].”
Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
Rosa, M. N. D. P., Hessel, G., & Tommaso, A. M. A. D. (2008) · PubMed · Cited by 2
Viral Hepatitis
Hu, D. J., Bower, W. A., & Ward, J. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4060-3.00012-0 · Cited by 2
Hepatitis A Virus
Averhoff, F. M., Khudyakov, Y. E., & Bell, B. P. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00176-4 · Cited by 2
Acute Viral Hepatitis
Ghany, M. G., & Liang, T. J. (2008) · Textbook of Gastroenterology · doi:10.1002/9781444303254.ch80 · Cited by 2
Clinical Differences According to Genotype in Acute Viral Hepatitis A in Daejeon, Korea
Lee, Y. W., Yang, H. W., Lee, J. A., Yun, K. H., Yang, S. E., Lee, M. J., Park, S. Y., Kim, S. H., Lee, H. I., Lee, Y. J., et al. (2011) · The Korean Journal of Internal Medicine · Cited by 1
Hepatitis A vaccination among human immuno- deficiency virus (HIV)-infected adults: Current evidence and unanswered questions
Crane, H. M., Dhanireddy, S., Kim, H. N., Ramers, C. B., Dellit, T. H., Kitahata, M. M., & Harrington, R. D. (2012) · Journal of AIDS and HIV Research · doi:10.5897/jahr12.083 · Cited by 1
“Large-scale clinical trials were then performed to demonstrate the efficacy and safety of HAV vaccines (Clemens et al., 1995; Innis et al., 1994; Werzberger et al., 1992).”
Background
Hepatitis A Virus
Collier, M. G., & Nelson, N. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00237-1 · Cited by 1
HEPATITIS A VIRUS
Fiore, A. E., & Bell, B. P. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50185-0 · Cited by 1
Hepatovirus
Anderson, D. A., & Counihan, N. A. (2011) · Springer eBooks · doi:10.1007/978-0-387-95919-1_214 · Cited by 1
Hepatitis A Vaccination in Infants: The Ultimate Solution to A Long-Standing Public Health Problem
Letson, G. W., & Margolis, H. S. (2007) · Current Pediatric Reviews · doi:10.2174/157339607779941589 · Cited by 1
Hepatitis A Virus
Williford, S. E., & Lemon, S. M. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch48 · Cited by 1
“The identification of HAV and the demonstration that infection could be transmitted to marmosets and tamarins, and, later, to seronegative chimpanzees ushered in a new era of research on hepatitis A that culminated in the propagation of the virus in cell culture (7), molecular cloning and sequencing of the viral genom…”
Vaccines for Travel: Hepatitis A, Meningococcal Disease, and Typhoid Fever
Chen, L. H. (2011) · Cited by 1
Reisen und Hepatitis
Manns, M. P., & Schüler, A. (1999) · Der Internist · doi:10.1007/s001080050449 · Cited by 1
GUIDELINES FOR IMMUNIZATIONS IN HIV-INFECTED PATIENTS
Toerner, J. G., & Mathews, W. C. (1997) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70301-5 · Cited by 1
Hepatitis A Vaccine: Which Dose Is Best?-Reply
Steffen, R. P. (1995) · JAMA · doi:10.1001/jama.1995.03520370039030 · Cited by 1
Treatment of viral hepatitis
Carrasco, D., Newman, C., & Tyring, S. K. (2000) · Dermatologic Therapy · doi:10.1046/j.1529-8019.2000.00033.x · Cited by 1
“The vaccine produces immunity in 95% of patients after a booster and lasts 3–10 years (4,5).”
Background
Immunization in Hematopoietic Cell Transplantation
Edwards, K. M., & Gruber, W. C. (2000) · Fetal and Pediatric Pathology · doi:10.1080/15513810009168629 · Cited by 1
Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults.
Das, K., Jain, A., Rk, G., & Kar, P. (1999) · PubMed · Cited by 1
From Prevention to Antivirals
Jonas, M. M. (2000) · Cited by 1
Vaccines
Arora, A., Mendoza, N., Tremaine, A. M., & Tyring, S. K. (2008) · Springer eBooks · doi:10.1007/978-1-84800-165-7_33 · Cited by 1
Adult Immunization in Women and Men
Hodder, S., Chew, D., & Swaminathan, S. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00048-4
Immune Prophylaxis and Vaccinations
Fletcher, M. A., & Plotkin, S. A. (2002) · Elsevier eBooks · doi:10.1016/b978-044450884-3/50013-1
A marketing executive for a large multinational company is contemplating a business visit to Brazil. He has heard about a new "shot" to prevent hepatitis A. What precautions and advice should be given to prevent this risk?
Perry, G. F. (1996) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199604000-00009
Developments in childhood immunization
Reuman, P. D., Rathore, M. H., & Ayoub, E. M. (1996) · Current Problems in Pediatrics · doi:10.1016/s0045-9380(96)80026-0
Hepatitis b vaccination
Min, A. D., Walsh, A., & Bodenheimer, H. C. (2006) · Current Hepatology Reports · doi:10.1007/s11901-006-0004-1
V ACCINES TO P REVENT V IRAL H EPATITIS
Emon, S. T. M. L., & Homas, D. A. L. T. (1997)
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations. Prevention of Hepatitis A with the Hepatitis A Vaccine
Craig, A. S., & Schaffner, W. (2004)
ComplianceWithMultiple-DoseVaccineSchedules AmongOlderChildren,Adolescents,andAdults: ResultsFromaVaccineSafetyDatalinkStudy
Nelson, J. C., Zhao, S., Baggs, J. M., Donahue, J. G., Hambidge, S. J., Jacobsen, S. J., Klein, N. P., Naleway, A. L., Zangwill, K. M., & Jackson, L. A. (2009)
Attitudes About Hepatitis A Vaccine and Vaccineassociated Side Effects among Turkish Medical Students
Özsürekçi, Y., Ertüten, B., Öncel, E. K., & Kara, A. (2015) · Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection · doi:10.5152/ced.2015.1969

Authors: Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & Andre, F. E.
Corresponding author: Clemens, R.
ORCID: Clemens, R.
Venue: Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 1995-03-01
Volume: 171
Issue: Supplement 1
Pages: S44-S49
ISSN: 0022-1899 (ISSN-L)
1537-6613
DOI: 10.1093/infdis/171.supplement_1.s44
OpenAlex: W2077738168
Cited by: 223
References: 23
Citations by year: 2025: 3 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 10 · 2012: 8
FWCI: 13.72
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
Keywords: inactivated hepatitis A vaccine, vaccine safety, immunogenicity, seroconversion, antibody persistence, booster vaccination, vaccine-induced antibodies, hepatitis A prevention
MeSH terms: Adult, Child, Clinical Trials as Topic, Hepatitis A, Hepatitis Antibodies, Humans, Pilot Projects, Travel, Vaccines, Viral Hepatitis Vaccines, Vaccines, Inactivated, HIV Infections, Hepatitis A Virus, Human, Hepatitis A Vaccines, Hepatitis A Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical experience with an inactivated hepatitis A vaccine.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks